CorVel (CRVL) Stock Price, News & Analysis

Company Overview

CorVel Corporation is a provider of technology-enabled risk management and healthcare administration services. The company helps employers, insurance carriers, third-party administrators and government entities manage workers’ compensation, auto and liability claims, with an emphasis on controlling costs, coordinating care and improving claim outcomes.

Its services include claims administration, medical bill review, utilization review, case management, pharmacy benefit management, provider-network services and managed-care solutions. CorVel also provides software and analytics designed to support claims processing, compliance, payment accuracy and communication among injured employees, healthcare providers, employers and insurers.

Founded in 1987 and headquartered in Irvine, California, CorVel primarily serves customers across the United States through a national network of service professionals and healthcare providers. The company is led by Michael G. Combs, who serves as president and chief executive officer.

Key Stats

• Today's Range: $75.27 to $76.90
• 50-Day Range: $59.10 to $76.00
• 52-Week Range: $44.83 to $79.43
• Volume: 270,948 shs
• Average Volume: 215,305 shs
• Market Capitalization: $3.88 billion
• P/E Ratio: 33.78
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

CorVel Stock Analysis - MarketRank™

CorVel scored higher than 28% of companies evaluated by MarketBeat, and ranked 755th out of 885 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

CorVel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

CorVel has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CorVel is 33.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of CorVel is 33.78, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.34.

Price to Book Value per Share Ratio

CorVel has a P/B Ratio of 9.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.24% of the float of CorVel has been sold short.

Short Interest Ratio / Days to Cover

CorVel has a short interest ratio ("days to cover") of 5.74.

Change versus previous month

Short interest in CorVel has recently decreased by 3.37%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CorVel does not currently pay a dividend.

Dividend Growth

CorVel does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.19

News Sentiment

CorVel has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for CorVel this week, compared to 2 articles on an average week.

Company Ownership

• Score: 2.0 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CorVel insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $630,420.00 in company stock.

Percentage Held by Insiders

39.72% of the stock of CorVel is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

51.36% of the stock of CorVel is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/06/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:CRVL
• CIK: 874866
• Web: www.corvel.com
• Phone: (503) 222-3144
• Fax: 949-851-1469
• Employees: 5,239
• Year Founded: 1987

Profitability

• EPS (Trailing Twelve Months): $2.25
• Trailing P/E Ratio: 33.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $110.34 million
• Net Margins: 11.72%
• Pretax Margin: 15.37%
• Return on Equity: 29.92%
• Return on Assets: 17.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.94
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: $958.53 million
• Price / Sales: 4.04
• Cash Flow: $2.80 per share
• Price / Cash Flow: 27.17
• Book Value: $7.71 per share
• Price / Book: 9.86

Miscellaneous

• Outstanding Shares: 51,010,000
• Free Float: 30,748,000
• Market Cap: $3.88 billion
• Optionable: Optionable
• Beta: 1.05